-+ 0.00%
-+ 0.00%
-+ 0.00%

U.S. FDA APPROVES WELIREG® (BELZUTIFAN) PLUS LENVIMA® (LENVATINIB) FOR CERTAIN PREVIOUSLY TREATED ADULT PATIENTS WITH ADVANCED RENAL CELL CARCINOMA WITH A CLEAR CELL COMPONENT (CCRCC)

Reuters·09/25/2026 10:45:02

Please log in to view news